Modeling sequence evolution in acute HIV-1 infection

scientific article published on 04 August 2009

Modeling sequence evolution in acute HIV-1 infection is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JTBI.2009.07.038
P932PMC publication ID2760689
P698PubMed publication ID19660475
P5875ResearchGate publication ID26722513
P894zbMATH Open document ID1403.92296

P50authorMichael SaagQ6834090
Michael P. BuschQ6833284
Jesus F Salazar-GonzalezQ57415418
Brandon KeeleQ68690678
George M. ShawQ78514357
Brian GaschenQ117221701
Eric DelwartQ30004089
Bette KorberQ30505218
Beatrice H. HahnQ55293537
Tanmoy BhattacharyaQ55414889
Alan S. PerelsonQ55719625
P2093author name stringHa Youn Lee
Elena E Giorgi
Paul A Goepfert
J Michael Kilby
Gayathri S Athreya
Kimmy T Pham
P2860cites workRelaxed phylogenetics and dating with confidenceQ21146068
Genome sequencing in microfabricated high-density picolitre reactorsQ24544260
Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study GroupQ64130059
Clinical and epidemiologic features of primary HIV infectionQ71182378
Estimating the pattern of nucleotide substitutionQ72138097
Monte Carlo estimates of natural variation in HIV infectionQ80349860
Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversificationQ24817186
BEAST: Bayesian evolutionary analysis by sampling treesQ27860723
Timing the ancestor of the HIV-1 pandemic strainsQ28137904
Retroviral restriction by APOBEC proteinsQ28290721
Bayesian coalescent inference of past population dynamics from molecular sequencesQ28306728
Target cell APOBEC3C can induce limited G-to-A mutation in HIV-1Q28469342
Pairwise comparisons of mitochondrial DNA sequences in stable and exponentially growing populationsQ29547255
Antibody neutralization and escape by HIV-1Q29547345
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation timeQ29547822
Rapid evolution of the neutralizing antibody response to HIV type 1 infectionQ29618603
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionQ29619510
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptaseQ29619994
A new cell-based assay for measuring the forward mutation rate of HIV-1.Q30350023
Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleteriousQ31047702
Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1.Q33237376
Clinical picture of primary HIV infection presenting as a glandular-fever-like illnessQ33447605
Sexual transmission of HIV: infectiousness and preventionQ33593763
Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B.Q33780595
Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levelsQ33780649
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infectionQ33825654
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresisQ33881912
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infectionQ34228730
Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypesQ34439417
Maximum likelihood estimation of population growth rates based on the coalescentQ34604415
Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variantsQ34717113
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivoQ34858885
Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivityQ35101464
Envelope variants from women recently infected with clade A human immunodeficiency virus type 1 confer distinct phenotypes that are discerned by competition and neutralization experiments.Q35155451
Comparing likelihood and Bayesian coalescent estimation of population parametersQ35598550
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infectionQ35895554
Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral populationQ36025234
Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaquesQ36277228
Viral dynamics of acute HIV-1 infectionQ36375339
Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencingQ36540055
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infectionQ36647820
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variantsQ37145228
Simulation and prediction of the adaptive immune response to influenza A virus infectionQ37247935
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1.Q37273086
Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1Q37568289
Mapping trait loci by use of inferred ancestral recombination graphsQ41078342
Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell lineQ41219560
Inheritance of defective extremitiesQ43407028
Two-sample tests for comparing intra-individual genetic sequence diversity between populationsQ43419925
Gene genealogy in a population of variable sizeQ43497317
HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virusQ45732337
Modeling plasma virus concentration during primary HIV infectionQ45743854
Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infectionQ45771143
High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infectionQ45854355
Selective transmission of human immunodeficiency virus type-1 variants from mothers to infantsQ45867857
Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection.Q46013897
Intermittent low-level viremia in very early primary HIV-1 infection.Q46607265
A robust measure of HIV-1 population turnover within chronically infected individuals.Q47296134
Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmissionQ47878972
A stochastic modeling of early HIV-1 population dynamics.Q52066082
Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group.Q52070829
A stochastic model for early HIV-1 population dynamics.Q52230372
Stochastic modeling of the dynamics of CD4+ T-cell infection by HIV and some Monte Carlo studies.Q52251017
A stochastic model for primary HIV infection: optimal timing of therapy.Q54099933
P2507corrigendum / erratumCorrigendum to “Modeling sequence evolution in acute HIV-1 infection” [J. Theor. Biol. 261 (2009) 341–360]Q56792871
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectHIVQ15787
P6104maintained by WikiProjectWikiProject MathematicsQ8487137
P1104number of pages20
P304page(s)341-360
P577publication date2009-08-04
P1433published inJournal of Theoretical BiologyQ2153724
P1476titleModeling sequence evolution in acute HIV-1 infection
P478volume261

Reverse relations

cites work (P2860)
Q33966648A limited number of simian immunodeficiency virus (SIV) env variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251.
Q48049832A new pattern-based method for identifying recent HIV-1 infections from the viral env sequence
Q36167660A quantitative quasispecies theory-based model of virus escape mutation under immune selection
Q33653774A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays
Q30359547Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release
Q34185814Acute HIV-1 Infection
Q36667979Adaptation to the interferon-induced antiviral state by human and simian immunodeficiency viruses
Q38068990Benchmarking of viral haplotype reconstruction programmes: an overview of the capacities and limitations of currently available programmes
Q38063560Biology as population dynamics: heuristics for transmission risk
Q38721805Characterizing HIV-1 Splicing by Using Next-Generation Sequencing
Q91656913Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-infection Estimation towards Enhanced Vaccine Efficacy Assessment
Q41610618Complementary and synergistic activities of anti-V3, CD4bs and CD4i antibodies derived from a single individual can cover a wide range of HIV-1 strains
Q35788320Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China
Q53274310Cross-Sectional HIV Incidence Surveillance: A Benchmarking of Approaches for Estimating the 'Mean Duration of Recent Infection'.
Q57874529Cross-Sectional HIV Incidence Surveillance: A Benchmarking of Approaches for Estimating the ‘Mean Duration of Recent Infection’
Q28740329Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy
Q35140263Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes
Q37252894Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal Infection
Q35868993Designing a genome-based HIV incidence assay with high sensitivity and specificity
Q35140450Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.
Q64915534Development and validation of plasma miRNA biomarker signature panel for the detection of early HIV-1 infection.
Q28551914Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus
Q64997345Different pattern of stool and plasma gastrointestinal damage biomarkers during primary and chronic HIV infection.
Q47550759Dynamics of CD4 and CD8 T-Cell Subsets and Inflammatory Biomarkers during Early and Chronic HIV Infection in Mozambican Adults
Q36000736Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape
Q28482493Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing
Q37312719Enhancement of viral escape in HIV-1 Nef by STEP vaccination
Q40448856Enhancing Virion Tethering by BST2 Sensitizes Productively and Latently HIV-infected T cells to ADCC Mediated by Broadly Neutralizing Antibodies.
Q92553546Estimating the basic reproduction number of a pathogen in a single host when only a single founder successfully infects
Q57484166Estimating the mutational fitness effects distribution during early HIV infection
Q35143626Estimating the timing of mother-to-child transmission of the human immunodeficiency virus type 1 using a viral molecular evolution model
Q33727328Estimating time since infection in early homogeneous HIV-1 samples using a poisson model
Q55424702Estimation of delay to diagnosis and incidence in HIV using indirect evidence of infection dates.
Q35077423Evolution of drug-resistant viral populations during interruption of antiretroviral therapy
Q42199105Forensic interpretation of molecular variation on networks of disease transmission and genetic inheritance.
Q35826158Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages
Q34290999Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeys
Q50041335HIITE: HIV-1 Incidence and Infection Time Estimator.
Q36526615HIV transmission
Q35895988HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins
Q33582135High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.
Q27318508Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques
Q35172385Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4
Q34038460Identifying and characterizing recently transmitted viruses
Q36495198Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assay
Q30596338Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository
Q35696991Innate immunity in acute HIV-1 infection
Q59357124Interaction Between Macrophage Migration Inhibitory Factor and CD74 in Human Immunodeficiency Virus Type I Infected Primary Monocyte-Derived Macrophages Triggers the Production of Proinflammatory Mediators and Enhances Infection of Unactivated CD4 T
Q35909939Investigating the Consequences of Interference between Multiple CD8+ T Cell Escape Mutations in Early HIV Infection
Q34802271Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users
Q34120840Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys
Q64968778Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users.
Q33545560Mathematical modeling of ultradeep sequencing data reveals that acute CD8+ T-lymphocyte responses exert strong selective pressure in simian immunodeficiency virus-infected macaques but still fail to clear founder epitope sequences
Q36887522Modeling sequence evolution in HIV-1 infection with recombination
Q21245370Modeling the within-host dynamics of HIV infection
Q26853307Modelling the course of an HIV infection: insights from ecology and evolution
Q28601925Molecular clock of HIV-1 envelope genes under early immune selection
Q89575126Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand
Q36532973Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones
Q52567234Neutral theory and rapidly evolving viral pathogens.
Q37252676Neutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challenge
Q93101105Parallel evolution of HIV-1 in a long-term experiment
Q33804531Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
Q37415771Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence.
Q58572549Phenotype, Polyfunctionality, and Antiviral Activity of Stimulated CD8 T-Cells From HIV Subjects Who Initiated cART at Different Time-Points After Acute Infection
Q37206422Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions
Q37272324Postintegration HIV-1 infection of cervical epithelial cells mediates contact-dependent productive infection of T cells
Q36305433Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions
Q38631923Primary infection by a human immunodeficiency virus with atypical coreceptor tropism
Q34395271Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate
Q34269570Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection.
Q34042642Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections
Q35581949SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma
Q37003000SPMM: estimating infection duration of multivariant HIV-1 infections
Q35018140Selective transmission of R5 HIV-1 variants: where is the gatekeeper?
Q33390855Seminal plasma induces inflammation and enhances HIV-1 replication in human cervical tissue explants
Q30407004Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection
Q34853144Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner
Q26826523Should we treat acute HIV infection?
Q35232811Simple mathematical models do not accurately predict early SIV dynamics
Q36433960Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification
Q40544201Single-use, electricity-free amplification device for detection of HIV-1
Q28483749Stochastic simulations suggest that HIV-1 survives close to its error threshold
Q33815539Stochastic theory of early viral infection: continuous versus burst production of virions
Q30238730Survivors Remorse: antibody-mediated protection against HIV-1.
Q40091554The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards
Q35926734The challenges of modelling antibody repertoire dynamics in HIV infection
Q39294118Time Until Emergence of HIV Test Reactivity Following Infection With HIV-1: Implications for Interpreting Test Results and Retesting After Exposure
Q42938571Timing, adherence, resistance, and ... persistence? new insight into the mechanisms of failure of HIV type 1 postexposure prophylaxis
Q33680395Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing
Q33849796Transmission of single and multiple viral variants in primary HIV-1 subtype C infection
Q37661224Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs
Q37395749Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes
Q26861425Using nonhuman primates to model HIV transmission
Q24600713Viral evolution and escape during acute HIV-1 infection
Q39400038Virus-Host Gene Interactions Define HIV-1 Disease Progression.
Q35690771Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells
Q33877419Wide variation in the multiplicity of HIV-1 infection among injection drug users
Q33619649Within-Epitope Interactions Can Bias CTL Escape Estimation in Early HIV Infection

Q56792871Corrigendum to “Modeling sequence evolution in acute HIV-1 infection” [J. Theor. Biol. 261 (2009) 341–360]main subjectP921

Search more.